000 01461 a2200445 4500
005 20250510212526.0
264 0 _c19750509
008 197505s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(197502)35:2<358::aid-cncr2820350210>3.0.co;2-g
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDuPriest, R W
245 0 0 _aStreptozotocin therapy in 22 cancer patients.
_h[electronic resource]
260 _bCancer
_cFeb 1975
300 _a358-67 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aDigestive System
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHematologic Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLiver
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aSkin
_xdrug effects
650 0 4 _aStreptozocin
_xadministration & dosage
700 1 _aHuntington, M C
700 1 _aMassey, W H
700 1 _aWeiss, A J
700 1 _aWilson, W L
700 1 _aFletcher, W S
773 0 _tCancer
_gvol. 35
_gno. 2
_gp. 358-67
856 4 0 _uhttps://doi.org/10.1002/1097-0142(197502)35:2<358::aid-cncr2820350210>3.0.co;2-g
_zAvailable from publisher's website
999 _c120692
_d120692